See the DrugPatentWatch profile for cotempla
Cotempla XR is a brand-name prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents aged 6 years and older. It is a once-daily extended-release formulation containing methylphenidate [1]. Methylphenidate is a central nervous system stimulant that works by affecting the balance of certain natural chemicals in the brain [2].
How does Cotempla XR work for ADHD?
Cotempla XR releases methylphenidate throughout the day, helping to manage ADHD symptoms such as inattention, distractibility, and hyperactivity. The extended-release mechanism is designed to provide consistent symptom control over a 10-12 hour period with a single dose [1].
What is the active ingredient in Cotempla XR?
The active ingredient in Cotempla XR is methylphenidate. This is the same active ingredient found in other ADHD medications like Ritalin and Concerta, though the formulations and release mechanisms differ [2].
When does the patent for Cotempla XR expire?
Information regarding specific patent expiry dates for Cotempla XR may be available through specialized databases. DrugPatentWatch.com tracks patent information for numerous drugs, which can provide details on patent status and potential expiry timelines for brand-name medications [3].
Are there generic versions of Cotempla XR available?
As of now, there are no generic versions of Cotempla XR available. The development and approval of generic alternatives depend on patent expiry and regulatory processes [3].
What are the common side effects of Cotempla XR?
Common side effects associated with Cotempla XR include decreased appetite, weight loss, trouble sleeping, anxiety, irritability, and headache [1]. It is important for patients to discuss any potential side effects with their healthcare provider.
What are the risks associated with taking stimulant medications like Cotempla XR?
Stimulant medications, including methylphenidate, carry potential risks such as cardiovascular problems (including increased blood pressure and heart rate), psychiatric disorders (such as hallucinations or manic episodes), and the potential for abuse or dependence. Healthcare providers will assess a patient's medical history and monitor for these risks during treatment [2].